CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,383,812
- in 18 filings, $13.4M under 10b5-1 plans
Net −$32,383,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-25 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $7.27 | $107K | 492,290 |
| 2026-03-25 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,060 | $14.27 | $272K | 473,230 |
| 2026-03-25 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 170,051 | ||
| 2026-03-24 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $7.27 | $107K | 496,628 |
| 2026-03-24 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,060 | $13.70 | $261K | 477,568 |
| 2026-03-24 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 184,773 | ||
| 2026-03-23 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $7.27 | $107K | 500,966 |
| 2026-03-23 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,060 | $13.83 | $264K | 481,906 |
| 2026-03-23 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 199,495 | ||
| 2026-03-20 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +3,939 | $6.55 | $26K | 494,521 |
| 2026-03-20 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +10,783 | $7.27 | $78K | 505,304 |
| 2026-03-20 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,060 | $13.37 | $255K | 486,244 |
| 2026-03-20 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −3,939 | 0 | ||
| 2026-03-20 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −10,783 | 214,217 | ||
| 2026-03-19 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $6.55 | $96K | 509,642 |
| 2026-03-19 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,060 | $13.18 | $251K | 490,582 |
| 2026-03-19 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 3,939 | ||
| 2026-03-18 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $6.55 | $96K | 513,980 |
| 2026-03-18 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,060 | $13.18 | $251K | 494,920 |
| 2026-03-18 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 18,661 |
Page 16 of 119 · 2,375 trades